105 related articles for article (PubMed ID: 17108212)
21. [Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma].
Zhou CZ; Zheng HT; Qiu GQ; Zhang F; He L; Peng ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1804-7. PubMed ID: 17054854
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
23. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
24. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
Frattini M; Gallino G; Signoroni S; Balestra D; Battaglia L; Sozzi G; Leo E; Pilotti S; Pierotti MA
Ann N Y Acad Sci; 2006 Sep; 1075():185-90. PubMed ID: 17108210
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
27. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma.
Kakimoto Y; Yamamoto N; Shibahara T
Oncol Rep; 2008 Nov; 20(5):1195-200. PubMed ID: 18949421
[TBL] [Abstract][Full Text] [Related]
30. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
31. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
[TBL] [Abstract][Full Text] [Related]
32. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects.
Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G
Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative analysis of circulating DNA in serum of cancer patients].
Tu H; Gao HF; Fu SL; Chen H
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):606-8. PubMed ID: 15634521
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
37. Free circulating DNA as possible tumour marker in colorectal cancer.
Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.
Choi CH; Lee KM; Choi JJ; Kim TJ; Kim WY; Lee JW; Lee SJ; Lee JH; Bae DS; Kim BG
Cancer Lett; 2007 Sep; 255(1):26-33. PubMed ID: 17467893
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
40. Circulating DNA and lung cancer.
Xue X; Zhu YM; Woll PJ
Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]